Investigator's Initiated Phase II Study for Pancreatic Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01659502
Recruitment Status : Unknown
Verified December 2013 by Tzivia Berkman, Tiltan Pharma Ltd..
Recruitment status was:  Not yet recruiting
First Posted : August 7, 2012
Last Update Posted : December 5, 2013
Information provided by (Responsible Party):
Tzivia Berkman, Tiltan Pharma Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2014
  Study Completion Date : No date given